Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells.
Open Access
- 1 October 1987
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 80 (4) , 1082-1089
- https://doi.org/10.1172/jci113164
Abstract
The extracellular matrix secreted by cultured bovine smooth muscle cells (BSMC) contains an endothelial type plasminogen activator (PA) inhibitor. When PA is incubated with the matrix, a high molecular weight complex containing a truncated PA inhibitor is released into the supernatant. The inhibitor also dissociates from the matrix by treatment with glycine, pH 2.7, in its intact, functionally active, 45-kD form, whereas treatment of the matrix with thrombin results in the release of a cleaved, inactive, 41 kD PA inhibitor. Bowes melanoma cells but not smooth muscle cells cultured on BSMC matrices decrease available matrix associated PA inhibitor. PA inhibitor incorporated into the extracellular matrix may serve an important role in the regulation of plasminogen activator mediated matrix degradation.Keywords
This publication has 50 references indexed in Scilit:
- Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1.Journal of Clinical Investigation, 1986
- Influence of the fast-acting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue-type plasminogen activator in rabbits. Interference of tissue-derived components.Journal of Clinical Investigation, 1986
- Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor.The Journal of Experimental Medicine, 1986
- An anticatalytic monoclonal antibody to avian plasminogen activator: Its effect on behavior of RSV-transformed chick fibroblastsCell, 1986
- Plasminogen activators catalyse conversion of inhibitor from fibrosarcoma cells to an inactive form with a lower apparent molecular massFEBS Letters, 1986
- Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells.Journal of Clinical Investigation, 1986
- The role of proteinase in cellular invasivenessBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1983
- The cellular target for the plasminogen activator, urokinase, in human fibroblasts - 66 000-dalton proteinBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1982
- Extracellular matrix.The Journal of cell biology, 1981
- Endogenous Activation of Latent Collagenase by Rheumatoid Synovial CellsNew England Journal of Medicine, 1977